Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silo Pharma, Inc. - Common Stock (NQ:SILO)

0.6285 +0.0085 (+1.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Silo Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Enters Device and CMC Development Master Plan to Support IND-Enabling Study of SPC-15
Via Investor Brand Network
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
Via Benzinga
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
From Silo Pharma, Inc.
Via GlobeNewswire
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is Silo Pharma (SILO) Stock Up 123% Today?
Silo Pharma stock is rocketing higher on Tuesday after the developmental stage biopharmaceutical company secured a new global license. 
Via InvestorPlace
Why Silo Pharma Stock Is Down Over 30%
Silo Pharma shares are trading lower by 31% during Wednesday's session. The company announced it has entered into agreements to sell 917,432 shares of common stock. 
Via Benzinga
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
Via Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
Via Benzinga
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
Via Investor Brand Network
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
Silo Pharma shares surge due to a global license agreement for Alzheimer's drug SPC-14, aiming to utilize the FDA's 505(b)(2) pathway. SPC-14 shows promise in stress reduction and cognitive... 
Via Benzinga
Dow Jumps 400 Points; US Retail Sales Flat For June
Via Benzinga
Topics Stocks
Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?
Greenpro Capital stock is down on Tuesday after shares of GRNQ underwent a major rally Monday with the announcement of a strategic alliance. 
Via InvestorPlace
Why Is Autonomix Medical (AMIX) Stock Down 17% Today?
Autonomix Medical stock is down on Tuesday but that's only due to AMIX shares coming off of a massive 130% rally on Monday. 
Via InvestorPlace
Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?
Conduit Pharmaceuticals stock is up with heavy trading of CDT shares on Tuesday after the company secured a new patent in Australia. 
Via InvestorPlace
Topics Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning! 
Via InvestorPlace
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters License Agreement with Columbia University for Lead Candidate Targeting PTSD, Stress-Induced Anxiety Disorders
Via Investor Brand Network
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD
Via Investor Brand Network
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
From Silo Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes on $2M Registered Direct Offering, Provides Update on SP-26 Ketamine Implant Therapeutic
Via Investor Brand Network
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Silo Pharma, Inc.
Via GlobeNewswire
Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Registered Direct Offering Estimated to Reach $2M
Via Investor Brand Network
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Gold Gains 1%; ISM Services PMI Surges In May
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.